ASIA News
The company said the AI integration has improved the biomarker detection of the Guardant cancer protein test by over 20%.
It plans to further expand across China's Greater Bay Area.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
Also, a new AI-powered health supplement app has gone live in South Korea.
Also, Dozee has received capital backing from British International Investment for its hospital bed upgrade project.
Veradigm is also keen on bringing its behavioural health data to Holmusk's rapidly growing database.
The company eyes overseas expansion and wants to offer more telemental health services.
It plans to secure more regulatory approvals for its AI pathology platform.
Also, AI cancer treatment software provider PVMed scores $14M in Series A funding.
It plays brain wave-based synchronised sounds to help users get into a deep sleep.